Medicare's new weight-loss drug discount leaves out patients with certain conditions
Medicare launched an 18-month pilot offering GLP-1 weight-loss drugs at $50 per month for some enrollees. However, patients with conditions like sleep apnea or Type 2 diabetes are ineligible, frustrating many. One retired professor with a BMI of 42 and a history of heart surgery was denied despite his high risk.
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “The Medicare GLP-1 discount is here, so why are some sick people excluded?.” Browse more stories.